William Welsh

Dr. William Welsh

Rutgers University-Robert Wood Johnson Medical School, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SKStanley G. Kimani
Stanley G. Kimani
SKSushil Kumar
Sushil Kumar
NBNitu Bansal
Nitu Bansal
KSKamalendra Singh
Kamalendra Singh
VKVladyslav Kholodovych
Vladyslav Kholodovych
RBRaymond Birge
Raymond Birge
TAM receptors (Tyro-3, Axl, and Mertk) are a family of three homologous type I receptor tyrosine kinases that are implicated in several human malignancies. Overexpression of TAMs and their major ligand Growth arrest-specific factor 6 (Gas6) is associated with more aggressive staging of cancers, poorer predicted patient survival, acquired drug resistance and metastasis. Here we describe small molecule inhibitors (RU-301 and RU-302) that target the extracellular domain of Axl at the interface of the Ig-1 ectodomain of Axl and the Lg-1 of Gas6. These inhibitors effectively block Gas6-inducible Axl receptor activation with low micromolar IC50s in cell-based reporter assays, inhibit Gas6-inducible motility in Axl-expressing cell lines, and suppress H1299 lung cancer tumor growth in a mouse xenograft NOD-SCIDγ model. Furthermore, using homology models and biochemical verifications, we show that RU301 and 302 also inhibit Gas6 inducible activation of Mertk and Tyro3 suggesting they can act as pan-TAM inhibitors that block the interface between the TAM Ig1 ectodomain and the Gas6 Lg domain. Together, these observations establish that small molecules that bind to the interface between TAM Ig1 domain and Gas6 Lg1 domain can inhibit TAM activation, and support the further development of small molecule Gas6-TAM interaction inhibitors as a novel class of cancer therapeutics.

YSYeongkwon Son
Yeongkwon Son
VMVladimir Mishin
Vladimir Mishin
William WelshWilliam Welsh
William Welsh
SLShou-En Lu
Shou-En Lu
JLJeffrey D. Laskin
Jeffrey D. Laskin
QMQingyu Meng
Qingyu Meng
Oxidative stress is one of the key mechanisms linking ambient particulate matter (PM) exposure with various adverse health effects. The oxidative potential of PM has been used to characterize the ability of PM induced oxidative stress. Hydroxyl radical (•OH) is the most destructive radical produced by PM. However, there is currently no high-throughput approach which can rapidly measure PM-induced •OH for a large number of samples with an automated system. This study evaluated four existing molecular probes (disodium terephthalate, 3′-p-(aminophenyl)fluorescein, coumarin-3-carboxylic acid, and sodium benzoate) for their applicability to measure •OH induced by PM in a high-throughput cell-free system using fluorescence techniques, based on both our experiments and on an assessment of the physicochemical properties of the probes reported in the literature. Disodium terephthalate (TPT) was the most applicable molecular probe to measure •OH induced by PM, due to its high solubility, high stability of the corresponding fluorescent product (i.e., 2-hydroxyterephthalic acid), high yield compared with the other molecular probes, and stable fluorescence intensity in a wide range of pH environments. TPT was applied in a high-throughput format to measure PM (NIST 1648a)-induced •OH, in phosphate buffered saline. The formed fluorescent product was measured at designated time points up to 2 h. The fluorescent product of TPT had a detection limit of 17.59 nM. The soluble fraction of PM contributed approximately 76.9% of the •OH induced by total PM, and the soluble metal ions of PM contributed 57.4% of the overall •OH formation. This study provides a promising cost-effective high-throughput method to measure •OH induced by PM on a routine basis.

14 August 2018 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
JKJoon S. Kang
Joon S. Kang
AZAntonia L. Zhang
Antonia L. Zhang
MFMohammad Faheem
Mohammad Faheem
CZCharles J. Zhang
Charles J. Zhang
NANi Ai
Ni Ai
Peter OelschlaegerPeter Oelschlaeger
Peter Oelschlaeger

1 December 2015 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
ALAlecander E. LaCuran
Alecander E. LaCuran
KPKevin M. Pegg
Kevin M. Pegg
ELEleanor M. Liu
Eleanor M. Liu
CBChristopher R. Bethel
Christopher R. Bethel
NANi Ai
Ni Ai
Peter OelschlaegerPeter Oelschlaeger
Peter Oelschlaeger
Antibiotic resistance in bacteria is ever changing and adapting, as once-novel β-lactam antibiotics are losing their efficacy, primarily due to the production of β-lactamases. Metallo-β-lactamases (MBLs) efficiently inactivate a broad range of β-lactam antibiotics, including carbapenems, and are often coexpressed with other antibacterial resistance factors. The rapid dissemination of MBLs and lack of novel antibacterials pose an imminent threat to global health. In an effort to better counter these resistance-conferring β-lactamases, an investigation of their natural evolution and resulting substrate specificity was employed. In this study, we elucidated the effects of different amino acid substitutions at position 67 in IMP-type MBLs on the ability to hydrolyze and confer resistance to a range of β-lactam antibiotics. Wild-type β-lactamases IMP-1 and IMP-10 and mutants IMP-1-V67A and IMP-1-V67I were characterized biophysically and biochemically, and MICs for Escherichia coli cells expressing these enzymes were determined. We found that all variants exhibited catalytic efficiencies ( k cat / K m ) equal to or higher than that of IMP-1 against all tested β-lactams except penicillins, against which IMP-1 and IMP-1-V67I showed the highest k cat / K m values. The substrate-specific effects of the different amino acid substitutions at position 67 are discussed in light of their side chain structures and possible interactions with the substrates. Docking calculations were employed to investigate interactions between different side chains and an inhibitor used as a β-lactam surrogate. The differences in binding affinities determined experimentally and computationally seem to be governed by hydrophobic interactions between residue 67 and the inhibitor and, by inference, the β-lactam substrates.


29 December 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YPYouyi Peng
Youyi Peng
QZQiang Zhang
Qiang Zhang
William WelshWilliam Welsh
William Welsh